XML 16 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Jun. 30, 2019
Jun. 30, 2018
Cash Flows from Operating Activities:        
Net loss $ (1,103,065) $ (505,716) $ (614,871) $ (351,390)
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities -        
Depreciation and amortization 75,449 23,482 38,554 27,216
Provision for doubtful accounts receivable     8,083 227,500
Stock-based compensation expense 426,778 356,103 473,326 52,341
Non-cash consulting expense 45,000 0 0 2,400
Changes in operating assets and liabilities        
Accounts receivable, net 686,030 (29,905) (723,369) (555,875)
Inventories, net (432,919) 14,222 137,510 (88,621)
Prepaid expenses 49,057 (68,447) (106,456) (15,006)
Accounts payable 359,079 (59,721) 69,365 48,580
Customer advances (139,667) (598,914) (432,000) 677,705
Accrued compensation and other (50,163) (85,236) 118,165 75,807
Net cash used in operating activities (84,421) (954,132) (1,031,693) 100,657
Cash Flows from Investing Activities:        
Cash acquired in business acquisition, net of $56,659 paid at year end     106,545 0
Cash paid for business acquisition (1,443,341) 0    
Additional patent costs (32,821) (2,532) (6,812) (17,189)
Purchases of property and equipment (110,012) (111,766) (140,038) (4,448)
Net cash used in investing activities (1,586,174) (114,298) (40,305) (21,637)
Cash Flows from Financing Activities:        
Payment of capital lease obligation (19,375) (6,666) (8,964) (8,392)
Gross proceeds from private placement of common stock 25,000 2,000,000 2,925,000 210,001
Gross proceeds from exercise of stock options 8,675 29,375 53,900 6,667
Private placement expense paid 0 (4,250) (12,250) (2,963)
Net cash provided from financing activities 14,300 2,018,459 2,957,686 205,313
Net increase (decrease) in cash and cash equivalents (1,656,295) 950,029 1,885,688 284,333
Cash and cash equivalents, beginning of period 2,288,426 402,738 402,738 118,405
Cash and cash equivalents, end of period 632,131 1,352,767 2,288,426 402,738
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Cash paid for income taxes 0 912 912  
Supplemental disclosure of non-cash financing and investing activities:        
Offering Costs Included in Accrued Liabilities 23,000 8,000    
Issuance of common stock for services     210,000 51,000
Private placement expenses incurred but not yet paid     12,250 0
Acquisition of Manufacturing Equipment Under Capital Lease $ 113,213 $ 0    
Issuance of common stock in settlement of accounts payable     $ 0 $ 40,000